nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Fluorouracil—skin cancer	0.448	0.676	CbGbCtD
Adefovir Dipivoxil—ABCC4—Fluorouracil—skin cancer	0.215	0.325	CbGbCtD
Adefovir Dipivoxil—NME1—neck—skin cancer	0.00749	0.0651	CbGeAlD
Adefovir Dipivoxil—AK4—nipple—skin cancer	0.0073	0.0634	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—female reproductive system—skin cancer	0.00651	0.0566	CbGeAlD
Adefovir Dipivoxil—ABCC5—hair follicle—skin cancer	0.00611	0.0531	CbGeAlD
Adefovir Dipivoxil—AK2—mammalian vulva—skin cancer	0.00576	0.0501	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—head—skin cancer	0.00544	0.0473	CbGeAlD
Adefovir Dipivoxil—NME1—connective tissue—skin cancer	0.00537	0.0467	CbGeAlD
Adefovir Dipivoxil—NME1—skin of body—skin cancer	0.00485	0.0421	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—skin cancer	0.0048	0.0417	CbGeAlD
Adefovir Dipivoxil—Nephropathy toxic—Bleomycin—skin cancer	0.00431	0.0195	CcSEcCtD
Adefovir Dipivoxil—AK4—mammalian vulva—skin cancer	0.00426	0.037	CbGeAlD
Adefovir Dipivoxil—NME1—lymphoid tissue—skin cancer	0.00393	0.0341	CbGeAlD
Adefovir Dipivoxil—NME1-NME2—lymph node—skin cancer	0.00381	0.0331	CbGeAlD
Adefovir Dipivoxil—NME1—female reproductive system—skin cancer	0.00379	0.0329	CbGeAlD
Adefovir Dipivoxil—Weight decreased—Vismodegib—skin cancer	0.00375	0.017	CcSEcCtD
Adefovir Dipivoxil—NME2—lymphoid tissue—skin cancer	0.0037	0.0321	CbGeAlD
Adefovir Dipivoxil—AK4—female reproductive system—skin cancer	0.00365	0.0317	CbGeAlD
Adefovir Dipivoxil—Bone pain—Imiquimod—skin cancer	0.00364	0.0164	CcSEcCtD
Adefovir Dipivoxil—NME2—female reproductive system—skin cancer	0.00357	0.031	CbGeAlD
Adefovir Dipivoxil—Connective tissue disorder—Vismodegib—skin cancer	0.00326	0.0147	CcSEcCtD
Adefovir Dipivoxil—NME1—head—skin cancer	0.00316	0.0275	CbGeAlD
Adefovir Dipivoxil—AK4—head—skin cancer	0.00305	0.0265	CbGeAlD
Adefovir Dipivoxil—NME2—head—skin cancer	0.00298	0.0259	CbGeAlD
Adefovir Dipivoxil—Myopathy—Temozolomide—skin cancer	0.00298	0.0135	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—nipple—skin cancer	0.00296	0.0257	CbGeAlD
Adefovir Dipivoxil—Hepatic function abnormal—Imiquimod—skin cancer	0.00289	0.0131	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Vismodegib—skin cancer	0.00289	0.0131	CcSEcCtD
Adefovir Dipivoxil—AK2—lymph node—skin cancer	0.00289	0.0251	CbGeAlD
Adefovir Dipivoxil—Back pain—Vismodegib—skin cancer	0.0028	0.0126	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Vismodegib—skin cancer	0.00246	0.0111	CcSEcCtD
Adefovir Dipivoxil—Foetor hepaticus—Docetaxel—skin cancer	0.00245	0.0111	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00244	0.011	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Vemurafenib—skin cancer	0.00232	0.0105	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Vismodegib—skin cancer	0.00231	0.0105	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Vismodegib—skin cancer	0.00229	0.0104	CcSEcCtD
Adefovir Dipivoxil—NME1—lymph node—skin cancer	0.00221	0.0192	CbGeAlD
Adefovir Dipivoxil—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00215	0.00971	CcSEcCtD
Adefovir Dipivoxil—AK4—lymph node—skin cancer	0.00213	0.0185	CbGeAlD
Adefovir Dipivoxil—SLC22A3—connective tissue—skin cancer	0.0021	0.0182	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—skin cancer	0.00209	0.0181	CbGeAlD
Adefovir Dipivoxil—Dyspepsia—Vismodegib—skin cancer	0.00208	0.00938	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vismodegib—skin cancer	0.00205	0.00927	CcSEcCtD
Adefovir Dipivoxil—Liver disorder—Docetaxel—skin cancer	0.00204	0.0092	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Vismodegib—skin cancer	0.00204	0.0092	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Vemurafenib—skin cancer	0.00202	0.00911	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Vismodegib—skin cancer	0.00193	0.00872	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Vismodegib—skin cancer	0.00187	0.00843	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Dactinomycin—skin cancer	0.00187	0.00842	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Imiquimod—skin cancer	0.00184	0.00833	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Imiquimod—skin cancer	0.00183	0.00826	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Vemurafenib—skin cancer	0.00179	0.00807	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Imiquimod—skin cancer	0.00174	0.00785	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—mammalian vulva—skin cancer	0.00173	0.015	CbGeAlD
Adefovir Dipivoxil—Urinary tract disorder—Imiquimod—skin cancer	0.00173	0.00781	CcSEcCtD
Adefovir Dipivoxil—Back pain—Vemurafenib—skin cancer	0.00173	0.00781	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Imiquimod—skin cancer	0.00172	0.00777	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Imiquimod—skin cancer	0.00172	0.00775	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vismodegib—skin cancer	0.00169	0.00765	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Temozolomide—skin cancer	0.00169	0.00762	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Vismodegib—skin cancer	0.00167	0.00754	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vismodegib—skin cancer	0.00161	0.00729	CcSEcCtD
Adefovir Dipivoxil—Cough—Vemurafenib—skin cancer	0.00156	0.00704	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Dactinomycin—skin cancer	0.00155	0.00699	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Imiquimod—skin cancer	0.00152	0.00688	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Vemurafenib—skin cancer	0.00152	0.00687	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00151	0.00682	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vismodegib—skin cancer	0.0015	0.00678	CcSEcCtD
Adefovir Dipivoxil—Rash—Vismodegib—skin cancer	0.00149	0.00672	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vismodegib—skin cancer	0.00149	0.00671	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—female reproductive system—skin cancer	0.00148	0.0129	CbGeAlD
Adefovir Dipivoxil—Back pain—Imiquimod—skin cancer	0.00147	0.00666	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Docetaxel—skin cancer	0.00145	0.00655	CcSEcCtD
Adefovir Dipivoxil—ABCC4—female reproductive system—skin cancer	0.00144	0.0125	CbGeAlD
Adefovir Dipivoxil—Nervous system disorder—Vemurafenib—skin cancer	0.00143	0.00646	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Vemurafenib—skin cancer	0.00142	0.0064	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Bleomycin—skin cancer	0.00141	0.00635	CcSEcCtD
Adefovir Dipivoxil—Nausea—Vismodegib—skin cancer	0.0014	0.00633	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Docetaxel—skin cancer	0.00139	0.00627	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00134	0.00604	CcSEcCtD
Adefovir Dipivoxil—Cough—Imiquimod—skin cancer	0.00133	0.006	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00133	0.006	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Bleomycin—skin cancer	0.00132	0.00596	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Imiquimod—skin cancer	0.0013	0.00586	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Imiquimod—skin cancer	0.0013	0.00586	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00129	0.00582	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Vemurafenib—skin cancer	0.00127	0.00572	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00126	0.00569	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—head—skin cancer	0.00124	0.0108	CbGeAlD
Adefovir Dipivoxil—Nervous system disorder—Imiquimod—skin cancer	0.00122	0.00551	CcSEcCtD
Adefovir Dipivoxil—ABCC5—lymph node—skin cancer	0.00121	0.0105	CbGeAlD
Adefovir Dipivoxil—Skin disorder—Imiquimod—skin cancer	0.00121	0.00546	CcSEcCtD
Adefovir Dipivoxil—ABCC4—head—skin cancer	0.0012	0.0104	CbGeAlD
Adefovir Dipivoxil—SLC22A8—head—skin cancer	0.00119	0.0103	CbGeAlD
Adefovir Dipivoxil—Weight decreased—Temozolomide—skin cancer	0.00119	0.00535	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Imiquimod—skin cancer	0.00119	0.00535	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Dactinomycin—skin cancer	0.00116	0.00524	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Vemurafenib—skin cancer	0.00115	0.00521	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Dactinomycin—skin cancer	0.00115	0.0052	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00113	0.00512	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Docetaxel—skin cancer	0.00112	0.00507	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Temozolomide—skin cancer	0.0011	0.00499	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Temozolomide—skin cancer	0.0011	0.00495	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Imiquimod—skin cancer	0.00109	0.00494	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Imiquimod—skin cancer	0.00108	0.00488	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Imiquimod—skin cancer	0.00107	0.00485	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Docetaxel—skin cancer	0.00106	0.00478	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Temozolomide—skin cancer	0.00105	0.00474	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Vemurafenib—skin cancer	0.00105	0.00472	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Temozolomide—skin cancer	0.00104	0.0047	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Temozolomide—skin cancer	0.00104	0.00468	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Vemurafenib—skin cancer	0.00103	0.00466	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Temozolomide—skin cancer	0.00103	0.00466	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Temozolomide—skin cancer	0.00103	0.00464	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Imiquimod—skin cancer	0.00102	0.00459	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Fluorouracil—skin cancer	0.00101	0.00456	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Bleomycin—skin cancer	0.001	0.00452	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Vemurafenib—skin cancer	0.000997	0.00451	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Imiquimod—skin cancer	0.000983	0.00444	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Imiquimod—skin cancer	0.000983	0.00444	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Fluorouracil—skin cancer	0.000959	0.00433	CcSEcCtD
Adefovir Dipivoxil—Cough—Bleomycin—skin cancer	0.000944	0.00427	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Dactinomycin—skin cancer	0.000933	0.00421	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Docetaxel—skin cancer	0.000931	0.0042	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Vemurafenib—skin cancer	0.000927	0.00419	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Bleomycin—skin cancer	0.000921	0.00416	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Bleomycin—skin cancer	0.000921	0.00416	CcSEcCtD
Adefovir Dipivoxil—Rash—Vemurafenib—skin cancer	0.000919	0.00415	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Vemurafenib—skin cancer	0.000918	0.00415	CcSEcCtD
Adefovir Dipivoxil—Headache—Vemurafenib—skin cancer	0.000913	0.00413	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Temozolomide—skin cancer	0.000913	0.00412	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Imiquimod—skin cancer	0.000892	0.00403	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000889	0.00402	CcSEcCtD
Adefovir Dipivoxil—Back pain—Temozolomide—skin cancer	0.000883	0.00399	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Imiquimod—skin cancer	0.00088	0.00397	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—skin cancer	0.000866	0.00753	CbGeAlD
Adefovir Dipivoxil—Nausea—Vemurafenib—skin cancer	0.000866	0.00391	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Bleomycin—skin cancer	0.000865	0.00391	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Dactinomycin—skin cancer	0.000859	0.00388	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Imiquimod—skin cancer	0.000851	0.00384	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Temozolomide—skin cancer	0.000844	0.00381	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Bleomycin—skin cancer	0.000842	0.0038	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lymph node—skin cancer	0.00084	0.0073	CbGeAlD
Adefovir Dipivoxil—Thrombocytopenia—Dactinomycin—skin cancer	0.000807	0.00364	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000805	0.00364	CcSEcCtD
Adefovir Dipivoxil—Cough—Temozolomide—skin cancer	0.000797	0.0036	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Imiquimod—skin cancer	0.00079	0.00357	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Docetaxel—skin cancer	0.000788	0.00356	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Dactinomycin—skin cancer	0.000785	0.00355	CcSEcCtD
Adefovir Dipivoxil—Rash—Imiquimod—skin cancer	0.000784	0.00354	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Imiquimod—skin cancer	0.000783	0.00354	CcSEcCtD
Adefovir Dipivoxil—Headache—Imiquimod—skin cancer	0.000779	0.00352	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Fluorouracil—skin cancer	0.000777	0.00351	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Temozolomide—skin cancer	0.000777	0.00351	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000772	0.00349	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Bleomycin—skin cancer	0.000768	0.00347	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Docetaxel—skin cancer	0.000764	0.00345	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Docetaxel—skin cancer	0.000757	0.00342	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000751	0.00339	CcSEcCtD
Adefovir Dipivoxil—Nausea—Imiquimod—skin cancer	0.000738	0.00334	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Docetaxel—skin cancer	0.000735	0.00332	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Temozolomide—skin cancer	0.000731	0.0033	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Temozolomide—skin cancer	0.000729	0.0033	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Temozolomide—skin cancer	0.000724	0.00327	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Fluorouracil—skin cancer	0.000716	0.00323	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Fluorouracil—skin cancer	0.000716	0.00323	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Dactinomycin—skin cancer	0.000716	0.00323	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Temozolomide—skin cancer	0.00071	0.00321	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Bleomycin—skin cancer	0.000698	0.00315	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Docetaxel—skin cancer	0.000697	0.00315	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Docetaxel—skin cancer	0.000692	0.00313	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Docetaxel—skin cancer	0.000689	0.00311	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Docetaxel—skin cancer	0.000685	0.0031	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Docetaxel—skin cancer	0.000684	0.00309	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000679	0.00307	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Dactinomycin—skin cancer	0.000674	0.00304	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Fluorouracil—skin cancer	0.000673	0.00304	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Fluorouracil—skin cancer	0.000672	0.00304	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Temozolomide—skin cancer	0.000656	0.00296	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Fluorouracil—skin cancer	0.000654	0.00296	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Dactinomycin—skin cancer	0.000651	0.00294	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Dactinomycin—skin cancer	0.000651	0.00294	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Temozolomide—skin cancer	0.000648	0.00293	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Temozolomide—skin cancer	0.000643	0.00291	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Bleomycin—skin cancer	0.000634	0.00286	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000625	0.00283	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Bleomycin—skin cancer	0.000625	0.00282	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Temozolomide—skin cancer	0.000609	0.00275	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Docetaxel—skin cancer	0.000607	0.00274	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Fluorouracil—skin cancer	0.000604	0.00273	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Fluorouracil—skin cancer	0.000597	0.0027	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000593	0.00268	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Dactinomycin—skin cancer	0.000591	0.00267	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Temozolomide—skin cancer	0.000589	0.00266	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Temozolomide—skin cancer	0.000589	0.00266	CcSEcCtD
Adefovir Dipivoxil—Back pain—Docetaxel—skin cancer	0.000587	0.00265	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Dactinomycin—skin cancer	0.000564	0.00255	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Bleomycin—skin cancer	0.000562	0.00254	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Docetaxel—skin cancer	0.000561	0.00253	CcSEcCtD
Adefovir Dipivoxil—Rash—Bleomycin—skin cancer	0.000557	0.00252	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Bleomycin—skin cancer	0.000556	0.00251	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Fluorouracil—skin cancer	0.000543	0.00245	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Temozolomide—skin cancer	0.000535	0.00241	CcSEcCtD
Adefovir Dipivoxil—Cough—Docetaxel—skin cancer	0.00053	0.00239	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Temozolomide—skin cancer	0.000527	0.00238	CcSEcCtD
Adefovir Dipivoxil—Nausea—Bleomycin—skin cancer	0.000525	0.00237	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Dactinomycin—skin cancer	0.000524	0.00237	CcSEcCtD
Adefovir Dipivoxil—Rash—Dactinomycin—skin cancer	0.000519	0.00235	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Docetaxel—skin cancer	0.000517	0.00233	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Docetaxel—skin cancer	0.000517	0.00233	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000513	0.00232	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Temozolomide—skin cancer	0.00051	0.0023	CcSEcCtD
Adefovir Dipivoxil—Nausea—Dactinomycin—skin cancer	0.000489	0.00221	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Docetaxel—skin cancer	0.000486	0.00219	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Fluorouracil—skin cancer	0.000486	0.00219	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Docetaxel—skin cancer	0.000485	0.00219	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Docetaxel—skin cancer	0.000481	0.00217	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Temozolomide—skin cancer	0.000474	0.00214	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Docetaxel—skin cancer	0.000472	0.00213	CcSEcCtD
Adefovir Dipivoxil—Rash—Temozolomide—skin cancer	0.00047	0.00212	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Fluorouracil—skin cancer	0.00047	0.00212	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Temozolomide—skin cancer	0.000469	0.00212	CcSEcCtD
Adefovir Dipivoxil—Headache—Temozolomide—skin cancer	0.000467	0.00211	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000451	0.00204	CcSEcCtD
Adefovir Dipivoxil—Nausea—Temozolomide—skin cancer	0.000443	0.002	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Fluorouracil—skin cancer	0.000436	0.00197	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Docetaxel—skin cancer	0.000436	0.00197	CcSEcCtD
Adefovir Dipivoxil—Rash—Fluorouracil—skin cancer	0.000433	0.00196	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Fluorouracil—skin cancer	0.000432	0.00195	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Docetaxel—skin cancer	0.000431	0.00195	CcSEcCtD
Adefovir Dipivoxil—Headache—Fluorouracil—skin cancer	0.00043	0.00194	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Docetaxel—skin cancer	0.000428	0.00193	CcSEcCtD
Adefovir Dipivoxil—Nausea—Fluorouracil—skin cancer	0.000408	0.00184	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Docetaxel—skin cancer	0.000405	0.00183	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Docetaxel—skin cancer	0.000392	0.00177	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Docetaxel—skin cancer	0.000392	0.00177	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Docetaxel—skin cancer	0.000355	0.00161	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Docetaxel—skin cancer	0.000351	0.00158	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Docetaxel—skin cancer	0.000339	0.00153	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Docetaxel—skin cancer	0.000315	0.00142	CcSEcCtD
Adefovir Dipivoxil—Rash—Docetaxel—skin cancer	0.000312	0.00141	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Docetaxel—skin cancer	0.000312	0.00141	CcSEcCtD
Adefovir Dipivoxil—Headache—Docetaxel—skin cancer	0.00031	0.0014	CcSEcCtD
Adefovir Dipivoxil—Nausea—Docetaxel—skin cancer	0.000294	0.00133	CcSEcCtD
